Companies with a Health score of at least 4, ordered by Health score.
Kancera AB (Publ), a biotechnology company, engages in the development and sale of drug candidates to pharmaceutical companies in Sweden and internationally.
LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden.
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based therapies for serious diseases.
IRLAB Therapeutics AB (publ), a research and development company, develops drugs for the treatment of Parkinson’s disease.
BioArctic AB (publ), a research intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disease in Sweden.
Dextech Medical AB develops drug candidates for application in urological oncology primarily for prostate cancer.
Follicum AB (publ), a biotech company, engages in the discovery and development of peptide-based drugs.
NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden.
Selectimmune Pharma AB (publ), a pharmaceutical company, develops drugs for the treatment of acute and chronic infections.
Initiator Pharma A/S, a biotech company, engages in the research and development of various drugs targeting medical needs within the central and peripheral nervous system.
Aegirbio AB, a diagnostic company, offers tests to monitor and optimize the dosage of biological drugs in Sweden.
Immunicum AB (publ) develops therapeutic cancer vaccines.
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases.
SenzaGen AB markets, sells, and performs in vitro genomic allergen rapid detection (GARD) sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals, complex mixtures, and cosmetic ingredients in Sweden and internationally.
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of diseases and conditions that affect the central nervous system.
CombiGene AB (publ) engages in the development of methods for the treatment of epilepsy and other neurological diseases.
Ascelia Pharma AB (publ) operates as an oncology-focused orphan drug development company in Sweden.
Eurocine Vaccines AB (publ) develops vaccines in Sweden.
Aptahem AB (publ), a biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.
PExA AB (publ) develops, produces, and markets a research instrument to study asthma and chronic obstructive pulmonary diseases.
RhoVac AB, a biotechnology company, engages in the research and development of therapeutic cancer vaccines in Sweden and Denmark.
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.
ODI Pharma AB (publ) produces pharmaceutical cannabis products in Europe.
Cyxone AB (publ), a clinical biotech company, develops immunomodulatory drugs for the treatment of autoimmune diseases.
